Nucleotide sequences regulating gene expression and constructs and methods utilizing same

Details for Australian Patent Application No. 2004219858 (hide)

Owner Evogene Ltd.

Inventors Ronen, Gil; Karchi, Hagai; Savir, Noa; Rabinovich, Larisa; Golan, Ezekiel; Meissner, Rafael; Zeliger, Naama

Agent Cullen & Co

Pub. Number AU-B-2004219858

PCT Pub. Number WO2004/081173

Priority 60/453,843 12.03.03 US

Filing date 11 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 8 January 2009

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/081173 Priority application(s): WO2004/081173

8 January 2009 Application Accepted

  Published as AU-B-2004219858

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004219867-Holographic sensor

2004219851-Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells